Search Results - "Borge, P Dayand"

Decreasing Premedication for Blood Transfusions: A Quality Improvement Project by Hole, Ashley, Budhai, Alexandra, King, Kerry, Borge, Jr, P Dayand

“…Premedication administration to patients who are to receive blood transfusions continues despite evidence of a lack of benefit when given to prevent febrile…”
Get full text

Making whole blood for trauma available (again): the American Red Cross experience by Young, Pampee P., Borge, P. Dayand

Get full text

Defining risk factors and presentations of allergic reactions to platelet transfusion by Savage, William J., MD, PhD, Hamilton, Robert G., PhD, DAMBLI, Tobian, Aaron A.R., MD, PhD, Milne, Ginger L., PhD, Kaufman, Richard M., MD, Savage, Jessica H., MD, MHS, Borge, P. Dayand, MD, PhD, Ness, Paul M., MD

“…Â Platelet recipient, n (%) Platelet donor, n (%) Never ATR (n = 44) ATR (n = 124) P value No ATR (n = 46) ATR (n = 87) P value Reported atopic history[low *]…”
Get full text

Management of human leukocyte antigen-mediated platelet transfusion refractoriness: Brief synopsis and recent literature review by Panch, Sandhya R, Vassallo, Ralph R, Adams, Sharon, Borge, Dayand P, Gammon, Richard, Gandhi, Manish J, Philogene, Mary, Sullivan, Harold C, Wu, YanYun, Kopko, Patricia

Get full text

Donor-specific antibody desensitization with daratumumab prior to haematopoietic cell transplant for sickle cell disease: A case report by Kunvarjee, Binni, Contreras Yametti, Gloria Paz, Blouin, Amanda G, Linder, Grace E, Borge, P Dayand, Maryamchik, Elena, Budhai, Alexandra, Gupta, Gaurav K, Scaradavou, Andromachi, Spitzer, Barbara G, Curran, Kevin J, Oved, Joseph H, Harris, Andrew C, Sharma, Akshay, Boelens, Jaap Jan, Cancio, Maria I

Get full text

HMA/VEN treatment modifications and associated outcomes in IDH -mutant AML by Chin, Kuo-Kai, Derkach, Andriy, Famulare, Christopher, Gupta, Gaurav K, Borge, P Dayand, Geyer, Mark B, Goldberg, Aaron D, Haque, Tamanna, Park, Jae H, Roeker, Lindsey E, Tallman, Martin S, Stahl, Maximilian, Stein, Eytan M

“…Hypomethylating agents (HMA) and venetoclax (VEN) are commonly used in patients with -mutated ( m) acute myeloid leukemia (AML) ineligible for induction…”
Get full text

U.S. cities will not meet blood product resuscitation standards during major mass casualty incidents: Results of a THOR‐AABB working party prospective analysis by Cannon, Jeremy W., Igra, Noah M., Borge, P. Dayand, Cap, Andrew P., Devine, Dana, Doughty, Heidi, Geng, Zhi, Guzman, Jessica F., Ness, Paul M., Jenkins, Donald H., Rajbhandary, Srijana, Schmulevich, Daniela, Stubbs, James R., Wiebe, Douglas J., Yazer, Mark H., Spinella, Philip C.

“…Background Mass casualty incidents (MCIs) create an immediate surge in blood product demand. We hypothesize local inventories in major U.S. cities would not…”
Get full text

Transfusion and component characteristics are not associated with allergic transfusion reactions to apheresis platelets by Savage, William J., Tobian, Aaron A.R., Savage, Jessica H., Hamilton, Robert G., Borge, P. Dayand, Kaufman, Richard M., Ness, Paul M.

“…Background Transfusion‐related characteristics have been hypothesized to cause allergic transfusion reactions (ATRs) but they have not been thoroughly studied…”
Get full text

Advances in Human Leukocyte Antigen Testing Technologies and Management Strategies for Platelet Transfusion Refractoriness by Sullivan, H Cliff, Borge, Jr, P Dayand, Gammon, Richard R, Gandhi, Manish, Philogene, Mary C, Wu, YanYun, Kopko, Patricia M

“…The blood bank is often consulted for transfusion support of patients with suspected platelet transfusion refractoriness (PTR). The workup is complex because…”
Get full text

The argument(s) for lowering the US minimum required content of apheresis platelet components by Benjamin, Richard J., Katz, Louis, Gammon, Richard R., Stramer, Susan L., Quinley, Eva

Get full text

Successful Control of Preexistent Active Infection by Granulocyte Transfusions During Conditioning Induced Cytopenia In Patients with Chronic Granulomatous Disease Undergoing Hematopoietic Stem Cell Transplant by Borge, P. Dayand, Theobald, Narda, DeCastro, Rosamma, Malech, Harry L., Leitman, Susan, Kang, Elizabeth M.

“…Abstract 1329 Chronic granulomatous disease (CGD) is a congenital disorder resulting from decreased or absent oxidase production by neutrophils. As a result,…”
Get full text